Bubs Australia Expands Infant Formula Reach in Vietnam
The company is partnering with a local distributor to make its products more accessible to families in the region.
Updated on Oct. 21, 2026 in Organic Food
Live Poll
Do you trust imported infant nutrition brands that partner with local distributors in your country?
Bubs Australia is expanding its infant formula distribution in Vietnam through a new partnership with HC Pharma. This move follows the company gaining permanent U.S. Food and Drug Administration authorization for three of its products in September 2026.
Why it matters
This partnership and recent regulatory successes mark a push to grow the brand's international presence. Such expansions highlight the ongoing efforts of formula manufacturers to navigate diverse global markets and health standards.
The U.S. Food and Drug Administration granted permanent authorization to 3 Bubs infant formula products in September 2026. While this regulatory milestone is confirmed, the total market reach of these products following the new Vietnam partnership remains under investigation.
The players
Bubs Australia
An Australian producer of infant formula and organic baby food products.
HC Pharma
A pharmaceutical and health product distributor based in Vietnam.
U.S. Food and Drug Administration
The federal agency responsible for protecting public health by ensuring the safety and efficacy of human and veterinary drugs and food products.
The details
The company is executing its regional expansion by leveraging local distribution networks managed by HC Pharma. Additionally, the organization held a scientific conference in Hanoi to engage directly with healthcare professionals and industry experts regarding its product portfolio. These initiatives are intended to strengthen trust and facilitate product adoption within the local medical community.
Timeline
Mid-February 2026: The prior stock price high for Bubs Australia.
September 2026: The FDA granted permanent authorization for three infant formula products.
October 21, 2026: The company relaunched its products in the Vietnamese market.
Health Landscape
This development follows the diversification of global supply chains triggered by the 2022 U.S. infant formula supply crisis. It highlights how manufacturers are increasingly seeking broad regulatory validation to support their expansion into international markets.
Parents should continue to consult with their pediatricians regarding the most appropriate infant formula choices based on their baby's specific nutritional needs. The safety and suitability of any formula remains a topic for direct discussion with a qualified healthcare provider.
The takeaway
Reliable access to infant nutrition remains a global priority for families and health systems alike. When navigating product options, always prioritize formulas that have met rigorous safety standards and discuss any dietary transitions with your pediatrician.
Further reading
For more information on the evolving standards for infant nutrition, visit our Organic Food section.
Source note: This article includes information reported by Inside FMCG.
Live Poll
Do you trust imported infant nutrition brands that partner with local distributors in your country?
